Nucleocapsid as a next-generation COVID-19 vaccine candidate

Multiple new variants of the SARS-CoV-2 virus have emerged globally, due to viral mutation. The majority of COVID-19 vaccines contain SARS-CoV-2 spike protein, which is susceptible to mutation. It is known that protection against COVID-19 after two doses of mRNA vaccine continuously wanes over time....

Descripción completa

Detalles Bibliográficos
Autores principales: Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Hedjran, Farah, Sanchez, Ana, Prokopenko, Elena, Reid, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250828/
https://www.ncbi.nlm.nih.gov/pubmed/35788417
http://dx.doi.org/10.1016/j.ijid.2022.06.046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250828/
https://www.ncbi.nlm.nih.gov/pubmed/35788417
http://dx.doi.org/10.1016/j.ijid.2022.06.046

Ejemplares similares